-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Downgrades Agilon Health to Sell, Raises Price Target to $105

Benzinga·07/23/2026 11:30:12
Listen to the news
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Neutral to Sell and raises the price target from $80 to $105.